{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "3-oxypyridine and succinic acid derivatives",
      "alcohol withdrawal",
      "anxiety",
      "depression"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "\u041f\u0440\u043e\u0432\u0435\u0441\u0442\u0438 \u0441\u0440\u0430\u0432\u043d\u0438\u0442\u0435\u043b\u044c\u043d\u044b\u0439 \u0430\u043d\u0430\u043b\u0438\u0437 \u0432\u043b\u0438\u044f\u043d\u0438\u044f \u043f\u0440\u043e\u0438\u0437\u0432\u043e\u0434\u043d\u044b\u0445 3-\u043e\u043a\u0441\u0438\u043f\u0438\u0440\u0438\u0434\u0438\u043d\u0430 \u0438 \u044f\u043d\u0442\u0430\u0440\u043d\u043e\u0439 \u043a\u0438\u0441\u043b\u043e\u0442\u044b (\u044d\u043c\u043e\u043a\u0441\u0438\u043f\u0438\u043d\u0430, \u0440\u0435\u0430\u043c\u0431\u0435\u0440\u0438\u043d\u0430 \u0438 \u043c\u0435\u043a\u0441\u0438\u0434\u043e\u043b\u0430) \u043d\u0430 \u0442\u0435\u043c\u043f \u043a\u0443\u043f\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u044f \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u043e\u0432 \u0442\u0440\u0435\u0432\u043e\u0433\u0438 \u0438 \u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0438 \u0432 \u043f\u0440\u043e\u0446\u0435\u0441\u0441\u0435 \u0441\u0442\u0430\u043d\u0434\u0430\u0440\u0442\u043d\u043e\u0433\u043e \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u0441\u0438\u043d\u0434\u0440\u043e\u043c\u0430 \u043e\u0442\u043c\u0435\u043d\u044b \u0430\u043b\u043a\u043e\u0433\u043e\u043b\u044f (\u0421\u041e\u0410).",
        "\u0411\u044b\u043b\u043e \u043f\u0440\u043e\u0432\u0435\u0434\u0435\u043d\u043e \u043a\u0440\u0430\u0442\u043a\u043e\u0441\u0440\u043e\u0447\u043d\u043e\u0435, \u043f\u0440\u043e\u0441\u043f\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0435, \u043f\u043b\u0430\u0446\u0435\u0431\u043e-\u043a\u043e\u043d\u0442\u0440\u043e\u043b\u0438\u0440\u0443\u0435\u043c\u043e\u0435, \u0434\u0432\u043e\u0439\u043d\u043e\u0435 \u00ab\u0441\u043b\u0435\u043f\u043e\u0435\u00bb, \u0440\u0430\u043d\u0434\u043e\u043c\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0435 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u0435 \u0432\u043b\u0438\u044f\u043d\u0438\u044f \u044d\u043c\u043e\u043a\u0441\u0438\u043f\u0438\u043d\u0430, \u0440\u0435\u0430\u043c\u0431\u0435\u0440\u0438\u043d\u0430 \u0438 \u043c\u0435\u043a\u0441\u0438\u0434\u043e\u043b\u0430 \u043d\u0430 \u0434\u0438\u043d\u0430\u043c\u0438\u043a\u0443 \u043a\u0443\u043f\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u044f \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u043f\u0440\u043e\u044f\u0432\u043b\u0435\u043d\u0438\u0439 \u0442\u0440\u0435\u0432\u043e\u0433\u0438 \u0438 \u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0438 \u0432 \u043f\u0440\u043e\u0446\u0435\u0441\u0441\u0435 14-\u0434\u043d\u0435\u0432\u043d\u043e\u0433\u043e \u0441\u0442\u0430\u0446\u0438\u043e\u043d\u0430\u0440\u043d\u043e\u0433\u043e \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u0421\u041e\u0410. \u0422\u044f\u0436\u0435\u0441\u0442\u044c \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u043e\u0432 \u0442\u0440\u0435\u0432\u043e\u0433\u0438 \u0443\u0447\u0438\u0442\u044b\u0432\u0430\u043b\u0438 \u0435\u0436\u0435\u0434\u043d\u0435\u0432\u043d\u043e \u0441 \u043f\u043e\u043c\u043e\u0449\u044c\u044e \u0448\u043a\u0430\u043b\u044b \u0442\u0440\u0435\u0432\u043e\u0433\u0438 \u0413\u0430\u043c\u0438\u043b\u044c\u0442\u043e\u043d\u0430 (HARS), \u043e\u0434\u043d\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u043e \u043e\u0446\u0435\u043d\u0438\u0432\u0430\u043b\u0438 \u0432\u044b\u0440\u0430\u0436\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0432\u043d\u043e\u0439 \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u0430\u0442\u0438\u043a\u0438 \u043f\u043e \u0448\u043a\u0430\u043b\u0435 \u041c\u043e\u043d\u0442\u0433\u043e\u043c\u0435\u0440\u0438-\u0410\u0441\u0431\u0435\u0440\u0433\u0430 (MADRS). \u041a\u0443\u043f\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0435 \u043e\u0442\u0434\u0435\u043b\u044c\u043d\u044b\u0445 \u043e\u0431\u044a\u0435\u043a\u0442\u0438\u0432\u043d\u044b\u0445 \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u043e\u0432 \u0442\u0440\u0435\u0432\u043e\u0433\u0438 \u0438 \u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0438 \u043e\u0442\u043c\u0435\u0447\u0430\u043b\u0438 \u043f\u0440\u0438 \u0434\u043e\u0441\u0442\u0438\u0436\u0435\u043d\u0438\u0438 \u043d\u0443\u043b\u0435\u0432\u044b\u0445 \u043e\u0446\u0435\u043d\u043e\u043a \u043f\u043e \u0441\u043e\u043e\u0442\u0432\u0435\u0442\u0441\u0442\u0432\u0443\u044e\u0449\u0438\u043c \u043f\u0443\u043d\u043a\u0442\u0430\u043c HARS \u0438 MADRS. \u0412 \u043f\u0435\u0440\u0432\u044b\u0439 \u0438 14-\u0439 \u0434\u043d\u0438 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f \u0434\u043e\u043f\u043e\u043b\u043d\u0438\u0442\u0435\u043b\u044c\u043d\u043e \u043f\u0440\u0438\u043c\u0435\u043d\u044f\u043b\u0438 \u0448\u043a\u0430\u043b\u0443 \u0441\u0430\u043c\u043e\u043e\u0446\u0435\u043d\u043a\u0438 \u0442\u0440\u0435\u0432\u043e\u0433\u0438 \u0426\u0443\u043d\u0433\u0430 (ZSRAS) \u0438 \u0448\u043a\u0430\u043b\u0443 \u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0438 \u0411\u0435\u043a\u0430 (BDI).",
        "\u0423\u0441\u0442\u0430\u043d\u043e\u0432\u043b\u0435\u043d\u043e, \u0447\u0442\u043e \u0432\u0441\u0435 \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u044b \u0441\u043e\u043a\u0440\u0430\u0449\u0430\u043b\u0438 \u043f\u0440\u043e\u0434\u043e\u043b\u0436\u0438\u0442\u0435\u043b\u044c\u043d\u043e\u0441\u0442\u044c \u043e\u0442\u0434\u0435\u043b\u044c\u043d\u044b\u0445 \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u043e\u0432 \u0442\u0440\u0435\u0432\u043e\u0433\u0438 \u0438 \u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0438 \u0432 \u043f\u0440\u043e\u0446\u0435\u0441\u0441\u0435 \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u0421\u041e\u0410. \u0412\u044b\u0440\u0430\u0436\u0435\u043d\u043d\u043e\u0441\u0442\u044c \u044d\u0442\u043e\u0433\u043e \u044d\u0444\u0444\u0435\u043a\u0442\u0430 \u0437\u0430\u0432\u0438\u0441\u0435\u043b\u0430 \u043e\u0442 \u043e\u0441\u043e\u0431\u0435\u043d\u043d\u043e\u0441\u0442\u0435\u0439 \u0445\u0438\u043c\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0441\u0442\u0440\u0443\u043a\u0442\u0443\u0440\u044b \u0438\u0437\u0443\u0447\u0430\u0435\u043c\u044b\u0445 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0445 \u0441\u0440\u0435\u0434\u0441\u0442\u0432. \u041c\u0435\u043a\u0441\u0438\u0434\u043e\u043b \u043d\u0430 25-50% \u0443\u0441\u043a\u043e\u0440\u044f\u043b \u043a\u0443\u043f\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0435 \u00ab\u0441\u0442\u0440\u0430\u0445\u043e\u0432\u00bb, \u00ab\u0440\u0435\u0441\u043f\u0438\u0440\u0430\u0442\u043e\u0440\u043d\u044b\u0445\u00bb \u0438 \u00ab\u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e-\u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u044b\u0445\u00bb \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u043e\u0432 \u0442\u0440\u0435\u0432\u043e\u0433\u0438 (\u043f\u043e HARS) \u0438 \u043d\u0430 28,5% \u0441\u043d\u0438\u0436\u0430\u043b \u043f\u0440\u043e\u0434\u043e\u043b\u0436\u0438\u0442\u0435\u043b\u044c\u043d\u043e\u0441\u0442\u044c \u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0432\u043d\u044b\u0445 \u043d\u0430\u0440\u0443\u0448\u0435\u043d\u0438\u0439 \u00ab\u0430\u043f\u043f\u0435\u0442\u0438\u0442\u0430\u00bb \u0438 \u00ab\u043a\u043e\u043d\u0446\u0435\u043d\u0442\u0440\u0430\u0446\u0438\u0438 \u0432\u043d\u0438\u043c\u0430\u043d\u0438\u044f\u00bb (\u043f\u043e MADRS). \u0420\u0435\u0430\u043c\u0431\u0435\u0440\u0438\u043d \u043d\u0430 17\u201450% \u0441\u043e\u043a\u0440\u0430\u0442\u0438\u043b \u0434\u043b\u0438\u0442\u0435\u043b\u044c\u043d\u043e\u0441\u0442\u044c \u00ab\u0433\u0430\u0441\u0442\u0440\u043e\u0438\u043d\u0442\u0435\u0441\u0442\u0438\u043d\u0430\u043b\u044c\u043d\u044b\u0445\u00bb \u0438 \u00ab\u0440\u0435\u0441\u043f\u0438\u0440\u0430\u0442\u043e\u0440\u043d\u044b\u0445\u00bb \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u043e\u0432 \u0442\u0440\u0435\u0432\u043e\u0433\u0438 \u043f\u043e HARS \u0438 \u043d\u0430 7% \u2014 \u00ab\u0432\u043d\u0443\u0442\u0440\u0435\u043d\u043d\u0435\u0433\u043e \u043d\u0430\u043f\u0440\u044f\u0436\u0435\u043d\u0438\u044f\u00bb \u043f\u043e MADRS. \u042d\u043c\u043e\u043a\u0441\u0438\u043f\u0438\u043d \u043d\u0430 10\u201450% \u0443\u0441\u043a\u043e\u0440\u044f\u043b \u043a\u0443\u043f\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0435 \u00ab\u0438\u043d\u0441\u043e\u043c\u043d\u0438\u0438\u00bb \u0438 \u00ab\u0440\u0435\u0441\u043f\u0438\u0440\u0430\u0442\u043e\u0440\u043d\u044b\u0445 \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u043e\u0432\u00bb \u043f\u043e HARS \u0438 \u043d\u0435 \u0432\u043b\u0438\u044f\u043b \u043d\u0430 \u043f\u0440\u043e\u0434\u043e\u043b\u0436\u0438\u0442\u0435\u043b\u044c\u043d\u043e\u0441\u0442\u044c \u043e\u0431\u044a\u0435\u043a\u0442\u0438\u0432\u043d\u044b\u0445 \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u043e\u0432 \u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0438 \u043f\u043e MADRS. \u042d\u043c\u043e\u043a\u0441\u0438\u043f\u0438\u043d \u0438 \u0440\u0435\u0430\u043c\u0431\u0435\u0440\u0438\u043d \u043d\u0430 32\u201437% \u0443\u043c\u0435\u043d\u044c\u0448\u0430\u043b\u0438 \u0442\u044f\u0436\u0435\u0441\u0442\u044c \u043a\u043e\u0433\u043d\u0438\u0442\u0438\u0432\u043d\u043e-\u0430\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u044b\u0445 \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u043e\u0432 \u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0438 \u043f\u043e \u0441\u0443\u0431\u044a\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0439 \u0448\u043a\u0430\u043b\u0435 BDI. \u041d\u0438 \u043e\u0434\u0438\u043d \u0438\u0437 \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u043e\u0432 \u043d\u0435 \u043f\u043e\u0432\u043b\u0438\u044f\u043b \u043d\u0430 \u0441\u0430\u043c\u043e\u043e\u0446\u0435\u043d\u043a\u0443 \u0442\u0440\u0435\u0432\u043e\u0433\u0438 \u043f\u043e ZSRAS. \u041d\u0430\u0438\u0431\u043e\u043b\u0435\u0435 \u0441\u0431\u0430\u043b\u0430\u043d\u0441\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u0443\u044e \u043a\u043e\u0440\u0440\u0435\u043a\u0446\u0438\u044e \u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0432\u043d\u043e\u0439 \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u0430\u0442\u0438\u043a\u0438 \u0432\u044b\u0437\u044b\u0432\u0430\u043b \u0440\u0435\u0430\u043c\u0431\u0435\u0440\u0438\u043d, \u043a\u043e\u0442\u043e\u0440\u044b\u0439 \u043e\u043a\u0430\u0437\u0430\u043b\u0441\u044f \u0435\u0434\u0438\u043d\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u043c \u0438\u0437 \u0438\u0437\u0443\u0447\u0435\u043d\u043d\u044b\u0445 \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u043e\u0432, \u043e\u0434\u043d\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u043e \u0441\u043d\u0438\u0436\u0430\u0432\u0448\u0438\u043c \u043a\u0430\u043a \u0434\u043b\u0438\u0442\u0435\u043b\u044c\u043d\u043e\u0441\u0442\u044c \u043e\u0431\u044a\u0435\u043a\u0442\u0438\u0432\u043d\u044b\u0445, \u0442\u0430\u043a \u0438 \u0442\u044f\u0436\u0435\u0441\u0442\u044c \u0441\u0443\u0431\u044a\u0435\u043a\u0442\u0438\u0432\u043d\u044b\u0445 \u043d\u0430\u0440\u0443\u0448\u0435\u043d\u0438\u0439 \u0430\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0433\u043e \u0441\u0442\u0430\u0442\u0443\u0441\u0430 \u043f\u0440\u0438 \u0430\u043b\u043a\u043e\u0433\u043e\u043b\u044c\u043d\u043e\u0439 \u0430\u0431\u0441\u0442\u0438\u043d\u0435\u043d\u0446\u0438\u0438."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34693691",
  "DateCompleted": {
    "Year": "2021",
    "Month": "10",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "26"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "rus"
    ],
    "ELocationID": [
      "10.17116/jnevro202112109163"
    ],
    "Journal": {
      "ISSN": "1997-7298",
      "JournalIssue": {
        "Volume": "121",
        "Issue": "9",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova",
      "ISOAbbreviation": "Zh Nevrol Psikhiatr Im S S Korsakova"
    },
    "ArticleTitle": "[An effect of 3-oxypyridine and succinic acid derivatives on the time of reduction of anxiety and depression symptoms in alcohol withdrawal treatment].",
    "Pagination": {
      "StartPage": "63",
      "EndPage": "71",
      "MedlinePgn": "63-71"
    },
    "Abstract": {
      "AbstractText": [
        "To compare the effect of 3-oxypyridine and succinic acid derivatives (emoxypine, reamberin, mexidol) on the time of reduction of anxiety and depression symptoms in the standard treatment of alcohol withdrawal syndrome (AWS).",
        "A short-term prospective placebo-controlled double blind randomized study of the effect of emoxypine, reamberin, mexidol on the dynamics of reduction of anxiety and depression clinical symptoms in the course of a 14-day day hospital treatment of AWS was conducted. The severity of anxiety symptoms was assessed on a daily basis by using the Hamilton Anxiety Rating Scale (HARS). Symptoms of depression were assessed with the Montgomery-Asberg Depression Rating Scale (MADRS). Reduction of certain objective anxiety and depression symptoms was noticed at 0 point of the corresponding HARS and MADRS items. On the 1<sup>st</sup> and 14<sup>th</sup> day of treatment, the Zung Self-Rating Anxiety Scale (ZSRAS) and the Beck Depression Inventory (BDI) were additionally used.",
        "All the studied drugs reduced the duration of certain anxiety and depression symptoms during AWS treatment. The degree of this effect depended on the features of the chemical structure of a drug. Mexidol accelerated the reduction of \u00abdread\u00bb, \u00abrespiratory\u00bb and \u00abcardiovascular\u00bb anxiety symptoms (HARS) by 25-50%. \u00abReduced appetite\u00bb and \u00abconcentration difficulty\u00bb (MADRS) improved by 28.5%. Reamberin reduced the duration of \u00abgastrointestinal\u00bb and \u00abrespiratory\u00bb anxiety symptoms (HARS) by 17-50% and \u00abinner tension\u00bb (MADRS) by 7%. Emoxypine accelerated the reduction of \u00abinsomnia\u00bb and \u00abrespiratory\u00bb symptoms (HARS) but did not affect the duration of objective depression symptoms (MADRS). Emoxypine and reamberin reduced the severity of affective and cognitive symptoms (BDI) by 32-37%. None of the drugs affected self-reported anxiety (ZSRAS). The most balanced treatment of depressive symptoms was provided by reamberin, which was the only of the studied drugs that simultaneously reduced both the duration of objective symptoms and the severity of subjective disorders of affective status in alcohol withdrawal."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-3186-3960"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "South Ural State Medical University, Chelyabinsk, Russia."
          }
        ],
        "LastName": "Volchegorskii",
        "ForeName": "I A",
        "Initials": "IA"
      },
      {
        "Identifier": [
          "0000-0001-8076-6310"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Chelyabinsk Regional Clinical Narcology Hospital, Chelyabinsk, Russia."
          }
        ],
        "LastName": "Izarovskii",
        "ForeName": "B V",
        "Initials": "BV"
      },
      {
        "Identifier": [
          "0000-0001-6327-2685"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "South Ural State Medical University, Chelyabinsk, Russia."
          }
        ],
        "LastName": "Shamaeva",
        "ForeName": "T N",
        "Initials": "TN"
      },
      {
        "Identifier": [
          "0000-0002-8290-5334"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "South Ural State University, Chelyabinsk, Russia."
          }
        ],
        "LastName": "Izarovskaia",
        "ForeName": "I V",
        "Initials": "IV"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Randomized Controlled Trial"
    ],
    "VernacularTitle": "Vliyanie proizvodnykh 3-oksipiridina i yantarnoi kisloty na temp kupirovaniya simptomov trevogi i depressii v protsesse lecheniya sindroma otmeny alkogolya."
  },
  "MedlineJournalInfo": {
    "Country": "Russia (Federation)",
    "MedlineTA": "Zh Nevrol Psikhiatr Im S S Korsakova",
    "NlmUniqueID": "9712194",
    "ISSNLinking": "1997-7298"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "3-oxypyridine"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Pyridines"
    },
    {
      "RegistryNumber": "AB6MNQ6J6L",
      "NameOfSubstance": "Succinic Acid"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prospective Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychiatric Status Rating Scales"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pyridines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Succinic Acid"
    }
  ]
}